Last updated: November 11, 2022
Sponsor: Sorlandet Hospital HF
Overall Status: Active - Recruiting
Phase
N/A
Condition
Circulation Disorders
Angina
Blood Clots
Treatment
N/AClinical Study ID
NCT05312320
20/09003-10-521
Ages 18-110 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Men and women ≥18 years old
- Acute MI during the last 6 weeks
- Informed consent for participation
Exclusion
Exclusion Criteria:
- Lack of ability to cooperate
- Known alcohol- or drug-abuse, or use of narcotics
- Pregnancy or breast-feeding
- Serious comorbidity with a life expectancy <12 months
- Unstable or refractory angina
- Uncontrolled hypertension
- Congestive heart failure (NYHA class III/IV)
- High-risk arrhythmias
- Hypertrophic obstructive and other cardiomyopathies
- Severe valvular disease
Study Design
Total Participants: 1200
Study Start date:
November 07, 2022
Estimated Completion Date:
November 30, 2024
Study Description
Connect with a study center
Www.Sefh.No
Arendal,
NorwayActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.